MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics
- 11 November 2025
- journal article
- research article
- Published by Springer Nature in Neuroradiology
- Vol. 67 (12) , 3509-3517
Abstract
Purpose Histopathological grading of IDH-mutant astrocytomas demonstrates limited prognostic accuracy. However, DNA methylation subclassification has demonstrated improved prognostication beyond histological grading. This study aimed to investigate the associations between imaging features, tumor volumetric data, and DNA methylation grade in IDH-mutant astrocytomas. Methods We analyzed imaging features and volumetric data for 72 patients diagnosed with IDH-mutant astrocytomas, who underwent preoperative MRI and DNA methylation profiling. VASARI features and multicompartmental volumetrics were evaluated. Logistic regression was used to identify imaging predictors of methylation subclass, WHO histologic grade, copy number variation (CNV), and CDKN2A/B homozygous deletion. Univariable and multivariable Cox proportional hazard models were also developed to assess these variables’ influence on overall survival and progression-free survival. Results Patients were classified into 27 methylation high-grade (A_IDH_HG) and 45 methylation low-grade (A_IDH_LG) tumors. Tumor volumes and proportions varied by methylation grade, CNV status, and WHO histologic grade, but not by CDKN2A/B status. Imaging features distinguished methylation subclasses with 75% accuracy (AUC = 0.77). Methylation high-grade subclass was associated with imaging features such as midline crossing, ependymal extension, and poorly defined enhancing margins. Predictive performance for WHO histologic grade, CNV status, and CDKN2A/B deletion was moderate (AUC = 0.67, 0.69, and 0.65, respectively). Methylation grade, CDKN2A/B status, VASARI features, and proportions of edema and non-contrast enhancing tumor were significantly associated with survival. Conclusion MRI-derived imaging features facilitate noninvasive prediction of DNA methylation subclass in IDH-mutant astrocytomas.Keywords
This publication has 25 references indexed in Scilit:
- Presurgical diagnosis of diffuse gliomas in adults: Post-WHO 2021 practical perspectives from radiologists in neuro-oncology unitsRadiología (English Edition), 2024
- The imaging features and prognosis of gliomas involving the subventricular zone: An MRI studyClinical Neurology and Neurosurgery, 2022
- Necrotic reshaping of the glioma microenvironment drives disease progressionActa Neuropathologica, 2022
- Novel, improved grading system(s) for IDH-mutant astrocytic gliomasActa Neuropathologica, 2018
- DNA methylation-based classification of central nervous system tumoursNature, 2018
- Whole Genome DNA Methylation Analysis of Human Glioblastoma Using Illumina BeadArrays2018
- DNA methylation: an epigenetic mark of cellular memoryExperimental & Molecular Medicine, 2017
- IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHOActa Neuropathologica, 2015
- Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groupsActa Neuropathologica, 2015
- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomasActa Neuropathologica, 2015